Testing effectiveness (Phase 2)Study completedNCT01431196
What this trial is testing
Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
Who this might be right for
Stage II Breast CancerStage III Breast Cancer
Clinica Universidad de Navarra, Universidad de Navarra 29